Bodin, Laurent <br/><br/>
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.  [electronic resource] 

 -  Blood  Jul 2005 
 - 135-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2005-01-0341  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acenocoumarol--administration & dosage<br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Anticoagulants--administration & dosage<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Carcinoma, Hepatocellular<br/>Cell Line, Tumor<br/>Cytochrome P-450 CYP2C9<br/>Drug Resistance--genetics<br/>Female<br/>Gene Frequency<br/>Genes, Reporter<br/>Haplotypes<br/>Humans<br/>Linear Models<br/>Liver Neoplasms<br/>Luciferases--genetics<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--genetics<br/>Predictive Value of Tests<br/>Vitamin K Epoxide Reductases